WILMINGTON – Building on its work toward a COVID-19 vaccine, the pharmaceutical giant AstraZeneca announced Tuesday morning that it has secured federal funding for a treatment using antibodies grown in labs. AstraZeneca, which has its ...
Limited time offer. New subscribers only.
Flash Sale! Subscribe to Delaware Business Times and save 50%.
Limited time offer. New subscribers only.